Join Dr. Joshua Sabari as he explores the emerging role of PD-(L)1 × VEGF bispecific antibodies in lung cancer. Through a review of their unique mechanisms of action and the latest clinical evidence, this expert-led microlearning module examines how these novel therapies may overcome the limitations of current treatment approaches and shape the future management of NSCLC and SCLC.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 12001 Sunrise Valley Dr.
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Clinical Informatics
- Communication & Shared Decision-Making
- Comprehensive & Board Review
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Foot & Ankle Surgery
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Infectious Disease
- Laryngology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Critical Care Medicine
- Pediatric Emergency Medicine
- Pediatric Infectious Diseases
- Pediatric Neurology
- Practice Management & Ethics
- Primary Care Sports Medicine
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Transplant Hepatology
- Transplant Surgery
- Vascular Neurology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Sports & Exercise Medicine
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Microlearning
- includes Online course / module
- Credit · Up to 0.25 credits
- Commercial Support
-
ReleasedJul 22, 2024
-
Last day to claim creditJul 15, 2027 9 months left
-
PVI, PeerView Institute for Medical Education Building a Better Backbone for NSCLC and SCLC Treatment With PD-(L)1xVEGF-A Bispecific Antibodies: Inducing Immune Invigoration, Simplifying Treatment Delivery, and Enhancing Clinical Outcomes
-
Clinical Care Options, LLC (dba Decera Clinical Education) Emerging Targeted Therapies for HNSCC: A Focus on EGFR-Directed Bispecific Antibodies
-
Creative Educational Concepts, Inc. Checkpoint Resistance and Beyond: Unlocking the Promise of Novel IO Agents in mNSCLC
-
MedAll +1 Evolving Paradigms in Lung Cancer: Module 4 Decision Trees for Patient Selection and Monitoring
-
MedAll +1 Evolving Paradigms in Lung Cancer: Module 1 Limitations of Current Treatments
-
MedAll +1 Evolving Paradigms in Lung Cancer: Clinical Integration of PD-(L)1 × VEGF Bispecific Therapy – Expert Podcast
